Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2020-06-09

Clinical Trial Update: The Effects of Inhalational Anaesthetics in Cognitive Functions in Down Syndrome Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effects of inhalational anaesthetics on cognitive functions in individuals with Down syndrome, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Asklepieion Voulas General Hospital | Conditions: Down Syndrome | Phase 2 | Status: COMPLETED